Ellington Management Group’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-11,400	Closed	-$136K	–	105
2020 Q1	$136K	Buy	+11,400	New	+$136K	0.03%	465
2016 Q4	–	Sell	-25,800	Closed	-$168K	–	566
2016 Q3	$168K	Buy	25,800 +4,100	+19%	+$26.7K	0.05%	573
2016 Q2	$118K	Buy	+21,700	New	+$118K	0.16%	206